More Data Sought for Merck & Co., Inc.'s (JOBS) Gardasil in Older Women; 2nd FDA Delay on Gardasil Expansion

NEW YORK, Jan 9 (Reuters) - U.S. health regulators want longer-term data on the use of Merck & Co’s Gardasil cervical cancer vaccine in an older group of women before they will approve the vaccine for those women, the drugmaker said on Friday.